Infante, M.; Fabbri, A.; Padilla, N.; Pacifici, F.; Di Perna, P.; Vitiello, L.; Feraco, A.; Giuliano, M.; Passeri, M.; Caprio, M.;
et al. BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report. Vaccines 2022, 10, 1096.
https://doi.org/10.3390/vaccines10071096
AMA Style
Infante M, Fabbri A, Padilla N, Pacifici F, Di Perna P, Vitiello L, Feraco A, Giuliano M, Passeri M, Caprio M,
et al. BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report. Vaccines. 2022; 10(7):1096.
https://doi.org/10.3390/vaccines10071096
Chicago/Turabian Style
Infante, Marco, Andrea Fabbri, Nathalia Padilla, Francesca Pacifici, Pasquale Di Perna, Laura Vitiello, Alessandra Feraco, Maria Giuliano, Marina Passeri, Massimiliano Caprio,
and et al. 2022. "BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report" Vaccines 10, no. 7: 1096.
https://doi.org/10.3390/vaccines10071096
APA Style
Infante, M., Fabbri, A., Padilla, N., Pacifici, F., Di Perna, P., Vitiello, L., Feraco, A., Giuliano, M., Passeri, M., Caprio, M., Ricordi, C., Della-Morte, D., & Uccioli, L.
(2022). BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report. Vaccines, 10(7), 1096.
https://doi.org/10.3390/vaccines10071096